Mark Woods
Family Medicine · Ozark, MONPI 1558451435
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 297 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 12.5% — the pattern of someone who eats at a lot of different presentations.
Across 297 payments — averaging $14.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$524
- Daiichi Sankyo Inc.$391
- Pfizer$379
- AstraZeneca$367
- GSK$258
- Boehringer Ingelheim$237
- plus $2K from 24 others
What the payments were for
- Food & beverage$4,183100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 49 | $524 |
| Daiichi Sankyo Inc. | 10 | $391 |
| Pfizer | 51 | $379 |
| AstraZeneca | 18 | $367 |
| GSK | 27 | $258 |
| Boehringer Ingelheim | 12 | $237 |
| Lilly USA, LLC | 17 | $236 |
| Novo Nordisk | 12 | $226 |
| Amgen | 14 | $214 |
| Takeda Pharmaceuticals U.S.A., Inc. | 19 | $193 |
| Merck | 15 | $184 |
| Amarin Pharma, Inc. | 3 | $160 |
| Sanofi-aventis U.S. LLC | 13 | $140 |
| Radius Health, Inc. | 3 | $110 |
| Otsuka America Pharmaceutical, Inc. | 2 | $97 |
| Collegium Pharmaceutical, Inc. | 4 | $55 |
| Circassia Inc. | 3 | $51 |
| Kowa Pharmaceuticals America, Inc. | 4 | $48 |
| Astellas Pharma US Inc | 3 | $45 |
| Johnson & Johnson | 3 | $37 |
| Arbor Pharmaceuticals, Inc. | 2 | $34 |
| Mylan Specialty L.p. | 2 | $34 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $29 |
| Novartis | 2 | $26 |
| Portola Pharmaceuticals, LLC | 1 | $26 |
| Teva Pharmaceuticals USA, Inc. | 2 | $23 |
| Vanda Pharmaceuticals Inc. | 1 | $19 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
| Ultragenyx Pharmaceutical Inc. | 1 | $13 |
| Ironshore Pharmaceuticals Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- INJECTAFER$267
- Ozempic$125
- Vascepa$124
- JARDIANCE$124
How this compares
$4,183 in reported general payments places this provider in the 85th percentile of 2,203 family medicine providers in Missouri.
Other family medicine in Ozark
- Stephen AdamsSpringfield$636K
- Justin PuckettKirksville$568K
- Matthew BeckerditeOfallon$225K
- Roger CadySpringfield$175K
- James LasalleExcelsior Springs$130K
- Matthew TiefenbrunnSullivan$105K
- Ayobami OduwoleGrandview$92K
- Michael DonovanSaint Louis$78K
- Blair ThedingerKansas City$71K
- Christine MooreRaymore$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.